First Patient Cases Performed with Remanufactured da Vinci Xi Instruments
FDA clearance enables reuse of da Vinci Xi instruments, offering hospitals a new sourcing option.
FDA clearance enables reuse of da Vinci Xi instruments, offering hospitals a new sourcing option.
In a statement, the U.S. FDA said that it believes that a 30-day extension “will allow adequate time for interested persons to submit comments without significantly delaying guidance on these important issues.”
FDA clearance enables reuse of da Vinci Xi instruments, offering hospitals a new sourcing option.